Measuring the Lifelong Impact of Cancer Treatment on Quality of Life
Compromises between length and quality of life should be informed by thorough research.
Progress Against Cancer
Compromises between length and quality of life should be informed by thorough research.
Paying attention to the social determinants of health will promote greater equity in cancer outcomes for all.
For September, the editors of the nine AACR journals have chosen to highlight a clinical trial that evaluated an Hsp90 inhibitor for...
Prostate cancer is the most common non-skin cancer in men, and is the second leading cause of cancer-related death among men in the United States. Although there...
September is Childhood Cancer Awareness Month. Childhood cancer is relatively rare, but it is a devastating diagnosis that can...
Investigators present results from a phase III clinical trial of Trodelvy as a treatment for metastatic triple-negative breast cancer, and...
Pancreatic cancer is notoriously challenging to treat, due largely to the fact that the disease is often diagnosed after...
The AACR issues an extensive report on cancer disparities, and more news of the week from Cancer Today.
Doctors and researchers point out that instructions on scalp cooling were not formulated with Black patients in mind and...
A trial of the molecularly targeted therapy osimertinib for early-stage lung cancer finds that patients who take it go...